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Introduction
One of the main objectives of surgical oncology is to
restore bowel continuity and to preserve adequate
sphincter function in patients treated for rectal cancer. It
particularly concerns patients with tumors located in
the middle and lower rectum. Increasing knowledge
on cancer biology and rectal anatomy and physio-
logy, supported by constant improvement in treatment
methods, contribute to the growing number of sphincter-
saving procedures in the treatment of rectal cancer [1-
6]. Low anterior resection (LAR) with sphincter saving
fulfills the requirements of radical surgery and preserves
satisfactory quality of life in as many as 80% of rectal
cancer patients [7]. It is believed that in the future multi-
modal therapy will render abdominoperineal resection
of rectal cancer (APR) an obsolete operation. We still
observe that APR or Hartmann’s procedure are perfor-
med in more than 30% of radically operated rectal cancer
patients [8-11]. Sparing the sphincter is much easier when
the tumor is located in the upper part of the rectum, and
it is not always possible in tumors of the middle and lower
rectum. High volume center provides a better chance for
the treatment with sparing the sphincter [9, 12, 13].
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I n t r o d u c t i o n.  While sphincter preservation is quite a simple procedure in patients with tumors of the upper rectum, it still
remains the evolving method in low-lying rectal cancer. Several developments directly influence the increasing number of
sphincter saving procedures in patients with rectal cancer.
M e t h o d s.  Medical literature was reviewed to identify the optimal treatment modality for low-lying rectal cancer with the
intention of sphincter-sparing.
C o n c l u s i o n s.  Long-term preoperative radio-chemotherapy can downsize the tumor, downstage the disease, diminish the
risk of local recurrence and increase the chances for a sphincter-saving procedure. Partial resection of the anal sphincter is
sometimes necessary to reach R0 resection and spare the sphincter function. It can be performed without significant
impairment of the sphincter function. Low anterior resection with total mesorectal excision is a technically demanding
procedure, enabling sphincter-saving, preserving the genitourinary function, and warranting good oncological outcome.
Colonic reservoir used for bowel continuity reconstruction improves the quality of life.
Zaoszcz´dzenie zwieraczy odbytu u chorych z rakiem odbytnicy
W p r o w a d z e n i e.  O ile doÊç ∏atwo mo˝na zachowaç zwieracze odbytu u pacjenta z wysoko po∏o˝onym rakiem odbytnicy,
to w przypadku nisko po∏o˝onych nowotworów metody leczenia prowadzàce do zaoszcz´dzenia zwieraczy wcià˝ podlegajà
intensywnemu rozwojowi. Wiele osiàgni´ç bezpoÊrednio sprzyja wzrastajàcej liczbie operacji z zaoszcz´dzeniem zwieraczy
odbytu.
M e t o d y.  Na podstawie przeglàdu literatury medycznej przedstawiono optymalne metody leczenia nisko po∏o˝onego raka
odbytnicy, sprzyjajàce zaoszcz´dzeniu zwieraczy odbytu.
W n i o s k i.  Przedoperacyjna d∏ugotrwa∏a radiochemioterapia mo˝e doprowadziç do zmniejszenia masy guza, obni˝enia
stopnia zaawansowania choroby, zmniejszenia ryzyka nawrotu miejscowego oraz do zwi´kszenia szansy na zaoszcz´dzenie
zwieraczy. Niekiedy zaoszcz´dzenie zwieraczy w warunkach resekcji R0 wymaga usuni´cia cz´Êci aparatu zwieraczowego.
Mo˝na tego dokonaç bez znaczàcego ograniczenia jego sprawnoÊci. Niska przednia resekcja z ca∏kowitym usuni´ciem krezki
odbytnicy jest skomplikowanym technicznie zabiegiem. Umo˝liwia zaoszcz´dzenie zwieraczy odbytu, zachowanie sprawnoÊci
uk∏adu moczop∏ciowego oraz zapewnia dobry wynik leczenia onkologicznego. Wytworzenie zbiornika ka∏owego w celu
odtworzenia ciàg∏oÊci przewodu pokarmowego poprawia jakoÊç ˝ycia chorych po resekcji odbytnicy.
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Contraindications for sphincter saving
Anatomical integrity and functional effectiveness of the
sphincter apparatus preserve good control over defecation
after rectal resection, and decrease the symptoms of the
anterior resection syndrome. Patients with an anato-
mically impaired, functionally inadequate sphincter are
not candidates for sphincter-saving procedures [14]. Some
people, especially women with a history of childbirth,
present occult sphincter impairment [15]. The anterior
resection syndrome is usually unavoidable after rectal
resection with coloanal or low located colorectal
anastomosis [16]. Radiotherapy of the sphincter region
additionally aggravates the syndrome symptoms [3, 15].
Patients who do not meet the criteria for the sphincter-
sparing surgery present with the following: bulky tumor, in
tha case of which maneuvers leading to lifting the tumor
up before safe and oncologically appropriate tumor
resection cannot be undertaken. In patients with tumors
located close to the sphincter, when rectal resection, even
with partial sphincter excision, does not assure proper
resection margin, the sphincter apparatus is usually
sacrificed [5]. The age of the patient should not be
a contraindication to sphincter preservation. In patients
older than 75 years, similarly as in younger people, 85% of
persons with sphincter preservation did not observe any
serious trouble with sphincter function [14, 17]. Significant
co-morbidity may be an obstacle in performing coloanal
or low lying colorectal anastomosis [7].
Diagnostics before sphincter saving
Case history and careful clinical examination should be
supported by imaging techniques 15, 18]. Endoanal and
endorectal ultrasound examination represent minimally
invasive, very sensitive and specific methods of recogni-
zing not only anal anatomical malformations, but also
allowing for accurate T feature estimation (staging
accuracy up to 89%). To a somewhat lesser extent even
the N feature estimation is possible. Staging accuracy
reaches 85%, and increases to 92% when ultrasound
guided fine needle node biopsy is performed [18]. MRI
with its endorectal coin is also very useful in showing the
anatomical integrity of the sphincter apparatus and in
staging the tumor preoperatively. It’s accuracy is com-
parable with that of endo-ultrasound examination. MRI
assures T feature estimation with an accuracy of up to
81%. The N feature can be diagnosed with an accuracy up
to 63% [19-21]. The pathological involvement of the
circumferential margin can be discerned by MRI with an
accuracy rate of 83% [22]. CT seems not to be as correct
as endou-ltrasound or MRI in preoperative staging of
low located rectal cancer [10, 18-21]. However, all these
methods are not accurate enough to restage the patient
correctly after neoadjuvant treatment, and their impact
upon qualification for less extensive surgery, even in the
case of complete clinical response, seems to be unclear
[11].
The choice of surgical treatment
Choosing the optimal method of surgical treatment one
must keep in mind that coloanal anastomoses associate
with a higher rate of postsurgical complications than
colorectal anastomoses [23].
Low located T1 rectal cancer characterized by
favorable pathoclinical features can be treated by local
excision with sphincter preservation [24-26]. It must be
a full-thickness excision with 1cm peripheral margin of the
bowel wall. Transanal endoscopic microsurgery was found
to be especially useful in these cases [25, 27]. In more
advanced tumors local excision is associated with an
unacceptable rate of local recurrences and with the risk of
undertreatment in spite of adjuvant therapy. In T1 tumors
with favorable pathoclinical features endocavitary
radiation alone, or in conjunction with external beam
radiotherapy, can be used alternatively to surgical excision
[26].
T2 and more advanced tumors require proctectomy
or partial rectal resection, together with the peripheral
lymph nodes [12, 24, 28-30]. Rectal resection with
complete excision of all fatty tissue enclosed within the
perirectal fascia, is the optimal surgical method in the
treatment of rectal cancer [2, 12, 13, 31, 32]. The
principles of this operation, practiced in many surgical
institutions for entire decades, had been widely pro-
pagated by Richard Heald, who described this procedure
as total mesorectal excision (TME). When performed
correctly, TME ensures the risk of local recurrence below
10% and provides better results of rectal cancer treatment
than standard rectal resection [12, 33, 34]. Even IV degree
tumors should be resected as during radical operation,
for this method provides the best level of local control of
the disease, facilitates sphincter saving, and improves the
quality of life significantly [35].
TME is an operation in the course of which the
rectum and the perirectal fat is sharply dissected in
a circumferential manner between the visceral and pelvic
fascias, with special care to save the visceral fascia intact,
and to preserve pelvic autonomic plexuses and nerves,
as this assures the satisfactory function of the genitouri-
nary tract (2,4,32,36). In spite of careful tissue preparation
after TME sexual functions may deteriorate (4). Urinary
function can also be impaired [4, 36]. However, this is
observed more often in patients who had undergone
TME during APR than after LAR. Preoperative radio-
chemotherapy aggravates functional complications [3, 4,
15, 37].
In case of rectal resection with the entire internal
sphincter or with partial resection of the internal
sphincter, coloanal anastomosis is placed below the
dentate line, but always with at least a 1 cm distal margin
[5]. In deep penetrating tumors, part of the external
sphincter together with the internal sphincter can also
be successfully excised without significant deterioration of
sphincter function, and with assurance of sphincter
adequacy in the future. The sphincter function and the
rate of local recurrences in patients with coloanal ana-
156
stomosis at the level of the dentate line are comparable to
those observed in case of coloanal anastomosis located in
the anal canal. Temporary oostomy seems to be a neces-
sity in all these cases [14, 15].
A Dutch study on TME showed that a majority of
properly trained surgeons from small hospitals who
practice colorectal surgery, can achieve very good results
of surgical treatment of rectal cancer patients, comparable
to those achieved by surgeons from large hospital. Other
studies have confirmed this observation [9, 12]. This
increases the need for proper training in TME – it should
be known to every colorectal surgeon, as such policy can
not only improve the oncological results of treatment,
but also increase the rate of sphincter sparing procedures
[12, 13, 34].
The impact of the specimen margin upon the
treatment results
In 7% to 20% of rectal cancer cases after TME without
neoadjuvant therapy the free circumferential margin is
≤1mm [32, 38]. A circumferential margin of less than 2
mm is recognized as positive and associated with a higher
risk of local recurrence and distant metastases [13, 39].
Some authors indicate the 3 mm radial margin as critical
for worse oncological outcome [8]. The quality of the
circumferential margin seems to influence the oncological
outcome of rectal cancer treatment more seriously than
the T feature, the N feature or the degree of tumor
differentiation [8, 13, 38, 39]. The sidewalls of the pelvis
are a natural barrier for its widening.
The distal margin plays a crucial role in the planning
of sphincter preservation. Tumor infiltration within the
bowel wall rarely exceeds 1 cm from the lowest edge of
the tumor or ulcer, and according to the studies on the
rate of local recurrences and late outcomes of rectal
cancer, a 2 cm margin is recognized as a safe distal margin
[28]. There are reports showing that a 1 cm distal margin
does not influence the results of a rectal cancer treatment
negatively, neither in patients after long-term preopera-
tive radio-chemotherapy [8, 40, 41], nor in the group
without neoadjuvant treatment, especially with the N0
feature [41]. Intraoperative microscopical examination
of the margin quality is highly recommended [8, 28].
A majority of patients with cancer located lower than 2
cm from the dentate line are qualified for APR. However,
many surgeons advocate proctectomy in these cases, even
in conjunction with partial sphincter resection, especially
if it affects its internal part [5, 15].
In tumors located more proximally in the rectum
partial rectal resection is recommended, together with
partial excision of the mesorectum, instead of excision
of the whole mesorectum. The mesorectum should be
cut perpendicularly to the bowel wall, 4 to 5 cm below
the tumor edge [12, 32]. Such treatment enables sphincter
preservation with restoration of bowel continuity and
renders the procedure simpler. According to some
authors, a 3 cm long distal mesorectal margin is also
sufficient for the radical treatment of rectal cancer [42].
The role of preoperative radio-chemotherapy in
rectal cancer
In low lying rectal cancers staged T3-4 and/or N(+) long-
term radiotherapy in conjunction with chemotherapy
appears to be very useful [12, 15, 43, 44]. Long-term
radiotherapy usually requires 45 Gy-54 Gy of radiation
with 1.8 Gy – 2.0 Gy per dose. 5-Fluorouracil is the most
often cytostatic agent used concomitantly to radiotherapy
[13, 44, 45]. Surgery is usually performed 6-8 weeks after
the termination of neoadjuvant treatment. In almost half
of the treated patients tumor downsizing has been
observed and in 8% to 24% of cases a complete patho-
logical remission has been reported [8, 10, 11, 44-46].
The rate of R0 resections has been increased [8, 43, 44].
In these patients downstaging related to the N feature
estimated preoperatively by endorectal ultrasound can
be obtained [10, 45, 47]. However, it does not correlate
with disease free survival and with the late oncological
outcome [8, 11, 46]. The delay of surgical treatment by
more than 8 weeks after radio-chemotherapy has no
impact on the rate of sphincter preservation [47].
Downsizing of the tumor facilitates surgical maneu-
vers in the pelvis during resection and increases the
chances of sphincter saving. Nevertheless, still exists the
query whether preoperative radio-chemotherapy, leading
to tumor downsizing and disease downstaging, allows for
a more proximal cutting line in the region initially invaded
by the tumor and now appearing normal [10, 11, 13, 44].
According to some authors as many as 75% of patients
with low lying rectal cancer qualified for APR before
neoadjuvant treatment may be re-qualified for LAR with
sphincter sparing despite a distal margin ranging between
1 mm and 1 cm [8]. It is reported that tumor location
seems to be a more serious predictor of late oncological
outcome than the method of its surgical treatment, which
is also a strong argument in favour of sphincter
preservation. According to other authors it is allowed in
cases with complete pathological tumor remission when
pT0N0 is confirmed microscopically [44]. According to
some studies there is no difference between the rate of
local recurrence and overall survival after surgical
treatment between complete and partial pathological
responders to neoadjuvant therapy, however there is
a trend towards better results in the group with complete
pathological response [11, 47]. Many surgeons do not
change their policy concerning the cutting line, even if
the tumor diminishes significantly [47]. It has been proven
that if the patients with complete clinical response are
not operated the rate of local recurrences is unacceptably
high. [46]. In primary non-resectable rectal cancer long-
term radio-chemotherapy can result in achieving 79% of
radical resections, and in producing a downstaging rate
from T4 to T0-2 to some 38% [43]. Late results for
downstaged group were similar to those achieved in
preliminary staged T1-2 rectal cancer patients, although
neodajuvant treatment has not improved survival.
On average local recurrence in patient subjected to
preoperative radio-chemotherapy and radical resection
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for rectal cancer appears after 3 years[10]. According to
the cited study a follow-up period of 5-7 years is
recommended for the exact estimation of the rate of local
recurrence in this group of patients. This means that
reports concerning the local control of the disease in
patients subjected to neoadjuvant therapy and surgery
with a median follow-up period of less than 3 years are of
limited value.
Widely used short-term radiotherapy, with the
delivery of 25 Gy over 5 days (Swedish model), and
operation 7-10 days after the onset of radiation therapy
successfully diminish the risk of local recurrence of rectal
cancer, also after TME (Dutch study). However, probably
because of the short time to surgery, this regime neither
downsizes the tumor nor downstages the disease and,
thus, it does not influence the chance for sphincter
preservation [13, 29, 30].
Brachytherapy followed by chemotherapy and other
treatment modalities appears to be a very promising tool
in increasing the chance for sphincter saving, as the rate of
complete clinical response in up to 68% of cases among
T2-T4 tumors brachytherapy is superior to the results
which can be achieved after long-term radiochemotherapy
[48]. The techniques of radiation delivery are constantly
improved to save the sphincter function in an optimal
way [3].
The colonic reservoirs
After LAR bowel continuity is restored by straight
coloanal or colorectal anastomosis or by anastomosis of
the anal canal or anorectal stump with the colonic
reservoir. Colonic reservoirs significantly improve the
quality of life, as they assure better control of defecation
after low anterior resection [14, 49-52]. They are usually
advocated after the resection of mid- and low-lying rectal
cancer. Optimal length of a colonic J-pouch reservoir
should not exceed 5-6 cm. Longer pouches cause more
trouble in emptying. Coloplasty is another method for
a colonic reservoir. 3-4 cm above the line of the
anastomosis the colon is incised 7-10 cm longitudinally
and sutured horizontally [15, 14, 49].
Pouches created by coloplasty enable easy access for
the stapling gun through the incised colon by an
abdominal approach, and at the same time protect the
sphincter complex from additional risk of injury while
the stapling gun is pushed through it. A kind of a colonic
reservoir may be obtained by “side-to-end” anastomosis
of the side of the bowel with the anal canal or with
the rectal stump [53]. Colonic J-pouches and colo-
plasty pouches seem to offer similar functional outcome
after low anterior resection, although coloplasty pouches
are easier to construct and more feasible than J-pouches
[49].
The role of laparoscopy in the treatment of rectal
cancer
Staplers increase the number of sphincter saving ope-
rations. They allow for safe bowel closure beneath the
tumor and for performing low anastomoses with the
double stapling technique. They facilitate the creation of
colonic reservoirs. They are also widely used during
laparoscopic rectal resection, especially with sphincter
sparing [54]. Laparoscopy is very useful if used in
particular stages of rectal resection. It may be a method
for the entire radical operation – also in LAR with
sphincter sparing. Late oncological and functional
outcomes are comparable with those achieved with open
surgery [54-56]. Some authors stress the need for
prospective randomized trials which should allow to
estimate the role of laparoscopy in the treatment of rectal
cancer, also in regard to the option with sphincter sparing.
Conclusions
Constant improvement in the multimodal treatment of
rectal cancer provides better chances for sphincter saving
in patients with low-lying tumors, even if the distance
from the tumor edge to the dentate line is shorter than 2
cm. Preoperative radio-chemotherapy can downsize the
tumor, downstage the disease, diminish the risk of local
recurrence and increase the chance for sphincter sparing.
TME is the optimal method of surgical treatment of low
lying rectal cancer, as it assures the best local control and
good oncological outcome and increases the chance for
LAR with sphincter saving. Partial resection of the anal
sphincter, performed to increase the resection margin,
still allows for sphincter preservation and a good
functional outcome, even if radiotherapy (which deterio-
rates sphincter function) is a part of the treatment.
Colonic reservoirs significantly decrease the symptoms
of low anterior resection syndrome and improve the
quality of life of the patients.
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